Omeros | OMER - Ebitda





Ebitda Alterar Data
Adma Biologics USD 61.07M 12.52M 2026-03
Alnylam Pharmaceuticals USD 245.34M 59.15M 2026-06
BioMarin Pharmaceutical USD 146.05M 170.22M 2026-03
Cytokinetics USD -169.32M 19.48M 2026-03
Gilead Sciences USD 3.51B 489M 2026-03
Heron Therapeutics USD -3.88M 5.63M 2024-09
Immunic USD -22.78M 753K 2024-06
Insmed USD -148.3M 165.88M 2026-03
Knight Therapeutics CAD 24.45M 3.46M 2025-12
MacroGenics USD -30.2M 52.15M 2026-03
Omeros USD -47.96M 7.39M 2023-09
Pacira USD 48.67M 8.43M 2026-06
Pfizer USD 6.01B 18M 2026-06
Sarepta Therapeutics USD 375.48M 627.68M 2026-03
United Therapeutics USD 355M 11.1M 2026-06
Vertex Pharmaceuticals USD 1.33B 130.5M 2026-06